Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/01/2922648/0/en/uniQure-Announces-Second-Quarter-2024-Financial-Results-and-Provides-Company-Update.html
https://www.fiercebiotech.com/biotech/biotechs-streamline-operations-and-cut-costs-layoffs-uniqure-arbutus-and-hillevax
https://www.globenewswire.com/news-release/2024/07/23/2917097/0/en/uniQure-Announces-Closing-of-Sale-of-Manufacturing-Facility-to-Genezen.html
https://www.globenewswire.com/en/news-release/2024/07/09/2910220/0/en/uniQure-Announces-Positive-Interim-Data-Update-Demonstrating-Slowing-of-Disease-Progression-in-Phase-I-II-Trials-of-AMT-130-for-Huntington-s-Disease.html
https://www.biopharmadive.com/news/uniqure-genezen-lexington-manufacturing-sale-gene-therapy/720266/
https://www.contractpharma.com/contents/view_breaking-news/2024-07-02/genezen-to-acquire-uniqures-commercial-gene-therapy-operations-in-lexington/?widget=listSection
https://www.globenewswire.com/news-release/2024/07/01/2906599/0/en/uniQure-Announces-Sale-of-Commercial-Manufacturing-Facility-to-Genezen.html
https://www.globenewswire.com/news-release/2024/06/03/2892124/0/en/uniQure-Receives-FDA-Regenerative-Medicine-Advanced-Therapy-RMAT-Designation-for-Investigational-Gene-Therapy-AMT-130-in-Huntington-s-Disease.html
https://www.globenewswire.com/news-release/2024/05/07/2876578/0/en/uniQure-Announces-First-Quarter-2024-Financial-Results-and-Highlights-Recent-Company-Progress.html
https://www.fiercepharma.com/pharma/kyowa-kirins-orchard-sets-new-gene-therapy-price-tag-425m-steepest-any-drug-us